Roger S McIntyre

Dr. Roger McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Chairman and Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. Dr. McIntyre is also Director for the Depression and Bipolar Support Alliance (DBSA) (Chicago, Illinois, USA).

Dr. McIntyre was named by Thomson Reuters in 2014 and 2015, as one of “The World’s Most Influential Scientific Minds”. This distinction is provided to researchers that publish the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade.

Dr. McIntyre is involved in multiple research endeavours that primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity.  His works broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.

Dr. McIntyre is extensively involved in medical education.  He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association (CPA) / Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.

Dr. McIntyre is a contributor to the Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Major Depressive Disorder and Bipolar Disorder. Dr. McIntyre was the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and as well a contributor to the CANMAT guidelines for the treatment of Depressive Disorders and Bipolar Disorders. Dr. McIntyre has published more than 400 articles/manuscripts and has edited and/or co-edited several textbooks on mood disorders.

Dr. McIntyre completed his medical degree at Dalhousie University.  He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.

Dr. McIntyre is involved in multiple research endeavours which aim to characterize the association between mood disorders, especially cognitive function and medical comorbidity.  Broadly, his work aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.
Expert Opin Drug Saf. 2017 Oct 30;:
Rong C, Carmona NE, Lee YL, Ragguett RM, Pan Z, Rosenblat JD, Subramaniapillai M, Shekotikhina M, Almatham F, Alageel A, Mansur R, Ho RC, McIntyre RS
CNS Spectr. 2017 Oct 30;:1-9
Christensen MC, Loft H, Florea I, McIntyre RS
Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):391-401
Woo YS, McIntyre RS, Kim JB, Lee MS, Kim JM, Yim HW, Jun TY
J Psychiatr Res. 2017 Oct 12;96:145-152
Nunes-Neto PR, Köhler CA, Schuch FB, Solmi M, Quevedo J, Maes M, Murru A, Vieta E, McIntyre RS, McElroy SL, Gearhardt AN, Stubbs B, Carvalho AF
PLoS One. 2017;12(10):e0186700
Lu Y, Ho CS, Liu X, Chua AN, Wang W, McIntyre RS, Ho RC
J Affect Disord. 2017 Oct 03;226:294-300
Giacobbe P, Rakita U, Lam R, Milev R, Kennedy SH, McIntyre RS
Int J Neuropsychopharmacol. 2017 Sep 08;:
Oluboka OJ, Katzman MA, Habert J, McIntosh D, MacQueen GM, Milev RV, McIntyre RS, Blier P
Acta Psychiatr Scand. 2017 Oct 11;:
Mansur RB, Brietzke E, McIntyre RS, Cao B, Lee Y, Japiassú L, Chen K, Lu R, Lu W, Li T, Xu G, Lin K
J Clin Psychiatry. 2017 Sep 26;:
Jain R, Maletic V, McIntyre RS

Pages


 

Head, Mood Disorders Psychopharmacology Unit, UHN
Professor, Departments of Psychiatry and Pharmacology and Toxicology, University of Toronto